CKS2 and RMI2 are two prognostic biomarkers of lung adenocarcinoma
Background Lung adenocarcinoma (ACA) is the most common subtype of non-small-cell lung cancer. About 70%–80% patients are diagnosed at an advanced stage; therefore, the survival rate is poor. It is urgent to discover accurate markers that can differentiate the late stages of lung ACA from the early...
में बचाया:
| मुख्य लेखकों: | , , , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
PeerJ Inc.
2020-10-01
|
| श्रृंखला: | PeerJ |
| विषय: | |
| ऑनलाइन पहुंच: | https://peerj.com/articles/10126.pdf |
| टैग: |
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|